TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3481627

Group type: EXPERIMENTAL
Intervention: Ofloxacin alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ofloxacin combined with fosfomycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ofloxacin combined with vancomycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vancomycin alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ofloxacin (1 and 4 mg/l)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ofloxacin combined with fosfomycin (one of three strains)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ofloxacin with fosfomycin (two of three strains)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ofloxacin with vancomycin (three strains)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Loading dose of 400 mg ofloxacin with subsequent doses of 200 mg
Number of subjects: 0
Study: 31758735

Group type: EXPERIMENTAL
Intervention: Sofosbuvir 200 mg/ledipasvir 45 mg (8-week treatment)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Sofosbuvir 200 mg/ledipasvir 45 mg (12-week treatment)
Number of subjects: 22
Study: 29476702

Group type: EXPERIMENTAL
Intervention: Mobile app CDST
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Print CDST
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control (no CDST)
Number of subjects: 144
Study: 27329084

Group type: EXPERIMENTAL
Intervention: 11C‐MeAIB PET
Number of subjects: 34

Group type: COMPARATOR
Intervention: 18F‐FDG PET
Number of subjects: 34

Group type: COMPARATOR
Intervention: MRI
Number of subjects: 34
Study: 24178584

Group type: EXPERIMENTAL
Intervention: Classroom-centered (CC) intervention
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: Family School Partnership (FSP)
Number of subjects: 678

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 678
Study: 22414490

Group type: EXPERIMENTAL
Intervention: Video game balance board program
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tai Chi
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard balance exercise program
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Overall sample (all interventions)
Number of subjects: 40
Study: 20207825

Group type: EXPERIMENTAL
Intervention: GH plus raloxifene (R; 60 mg/d)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: GH plus 17beta‐estradiol (E(2); 2 mg/d)
Number of subjects: 21

Group type: COMPARATOR
Intervention: GH therapy alone (0.5 mg/d)
Number of subjects: 21
Study: 18540803

Group type: EXPERIMENTAL
Intervention: lopinavir/ritonavir
Number of subjects: 155

Group type: COMPARATOR
Intervention: efavirenz
Number of subjects: 155
Study: 16108036

Group type: EXPERIMENTAL
Intervention: Albumin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Hydroxyethyl starch
Number of subjects: 20
Study: 12685518

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other stimulant medications
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapeutic trials with a duration or follow-up period of 12 months or more
Number of subjects: 0
Study: 10049982

Group type: EXPERIMENTAL
Intervention: High glycemic index meal
Number of subjects: 12

Group type: COMPARATOR
Intervention: Medium glycemic index meal
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low glycemic index meal
Number of subjects: 12
Study: 7585848

Group type: EXPERIMENTAL
Intervention: Regimen A (contents from a 30‐mg capsule placed in a tablespoonful of applesauce)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Regimen B (an intact 30‐mg capsule)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Regimen A
Number of subjects: 24

Group type: COMPARATOR
Intervention: Regimen B
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 24
Study: 2106837

Group type: EXPERIMENTAL
Intervention: UFT (1‐(2‐tetrahydrofuryl)‐5‐fluorouracil mixed with uracil) orally at a daily dose of 300 mg
Number of subjects: 29

Group type: COMPARATOR
Intervention: No further therapy
Number of subjects: 29
Study: 1164876

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine treatment
Number of subjects: 106

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 106

Group type: COMPARATOR
Intervention: Untreated control group (high-risk patients)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine treatment (low-risk patients)
Number of subjects: 106
Study: 31152911

Group type: EXPERIMENTAL
Intervention: Revefenacin 88 μg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Revefenacin 175 μg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 0
Study: 29178937

Group type: EXPERIMENTAL
Intervention: Levofloxacin 11 mg/kg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levofloxacin 14 mg/kg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levofloxacin 17 mg/kg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levofloxacin 20 mg/kg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levofloxacin doses (11, 14, 17, 20 mg/kg/day)
Number of subjects: 0
Study: 25209456

Group type: EXPERIMENTAL
Intervention: Ketoprofen 2%
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hydroxyzine 1%
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lidocaine 5%
Number of subjects: 30
Study: 23948958

Group type: EXPERIMENTAL
Intervention: High-dose statin therapy
Number of subjects: 826

Group type: COMPARATOR
Intervention: Low-dose/no statins
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Interventions in saphenous vein grafts, malapposed stents, overlap >3 mm, complex coronary anatomy
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Interventions in saphenous vein grafts, underexpanded or malapposed stents, history of myocardial infarction
Number of subjects: 826
Study: 21930596

Group type: EXPERIMENTAL
Intervention: IH with losartan (AT(1) receptor antagonist)
Number of subjects: 9

Group type: COMPARATOR
Intervention: IH with placebo medication
Number of subjects: 9

Group type: COMPARATOR
Intervention: Sham IH
Number of subjects: 9
Study: 20061584

Group type: EXPERIMENTAL
Intervention: Gemfibrozil (60 mg/kg/dose)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 97
Study: 16426275

Group type: EXPERIMENTAL
Intervention: Tension-type headache (TH)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Migraine (M)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Normal controls (NC)
Number of subjects: 114
Study: 15561035

Group type: EXPERIMENTAL
Intervention: Deep pericardial suture technique (group 1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Vacuum-assisted apical suction device (group 2)
Number of subjects: 20
Study: 12160759

Group type: EXPERIMENTAL
Intervention: Iridium-192 intracoronary radiation therapy (IRT)
Number of subjects: 130
Study: 9202916

Group type: EXPERIMENTAL
Intervention: Alizapride 100 mg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Droperidol 1 mg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ondansetron 8 mg
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 75
Study: 7955971

Group type: EXPERIMENTAL
Intervention: Twice daily isophane (Protaphane)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three times daily soluble insulin (Actrapid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Protaphane therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Actrapid therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin therapy (both regimens)
Number of subjects: 0
Study: 3297124

Group type: EXPERIMENTAL
Intervention: Indomethacin (375 mg over 3 days)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propranolol (circa 40 mg i.v. over 60 min)
Number of subjects: 12

Group type: COMPARATOR
Intervention: VIP infusion (6 pmol kg-1 min-1)
Number of subjects: 12
Study: 30335205

Group type: EXPERIMENTAL
Intervention: Contingent group (n = 20) received monetary incentives for negative breathalyzer samples.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Noncontingent group (n = 20) received matched monetary payments regardless of alcohol content.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Contingent group (n = 20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 27060177

Group type: EXPERIMENTAL
Intervention: Structured physical activity programme
Number of subjects: 947

Group type: COMPARATOR
Intervention: Health education programme
Number of subjects: 947
Study: 24972455

Group type: EXPERIMENTAL
Intervention: Citrulline
Number of subjects: 8

Group type: COMPARATOR
Intervention: Non-essential AA mixture (NEAA)
Number of subjects: 8
Study: 23776115

Group type: EXPERIMENTAL
Intervention: Exothermic mattresses (EMs)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Polyethylene bags (PBs) without EMs
Number of subjects: 72
Study: 21092183

Group type: EXPERIMENTAL
Intervention: Job aids-focused intervention
Number of subjects: 0
Study: 18212574

Group type: EXPERIMENTAL
Intervention: Continuous intrathecal analgesia with a 28-gauge catheter
Number of subjects: 429

Group type: COMPARATOR
Intervention: Continuous epidural analgesia with a 20-gauge catheter
Number of subjects: 429
Study: 16680933

Group type: EXPERIMENTAL
Intervention: Diphenhydramine 50 mg, 3 times daily
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Desloratadine 5 mg, once daily
Number of subjects: 610

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 610
Study: 15238047

Group type: EXPERIMENTAL
Intervention: Infants who saw an object hidden inside a container and were removed from the disappearance locale for 24 hr
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control infants who saw no disappearance
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Infants who returned to see the container in a different room
Number of subjects: 14
Study: 11549412

Group type: EXPERIMENTAL
Intervention: 2DSIS observer ratings on participants
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 2DSIS observer ratings on confederates
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Factor analysis of 2DSIS
Number of subjects: 59
Study: 9002102

Group type: EXPERIMENTAL
Intervention: C-aPDT vaccine (Chiron/Biocine)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: wDPT vaccine (Connaught)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Lederle aPDT vaccine
Number of subjects: 2000
Study: 8428857

Group type: EXPERIMENTAL
Intervention: Teaching session for parents
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (parents who did not attend the course)
Number of subjects: 26
Study: 3036724

Group type: EXPERIMENTAL
Intervention: sequential intermittent polychemotherapy (sq CT) after surgery
Number of subjects: 56

Group type: COMPARATOR
Intervention: standard chemotherapy (CT) after surgery
Number of subjects: 56
Study: 31343630

Group type: EXPERIMENTAL
Intervention: Knowledge Test Feedback Intervention (KTFI) and routine education
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine patient education
Number of subjects: 100
Study: 28069068

Group type: EXPERIMENTAL
Intervention: as-needed budesonide/formoterol 160/4.5 μg
Number of subjects: 7864

Group type: COMPARATOR
Intervention: placebo bid plus as-needed terbutaline 0.4 mg
Number of subjects: 7864

Group type: COMPARATOR
Intervention: budesonide 200 μg bid plus as-needed terbutaline 0.4 mg
Number of subjects: 7864
Study: 26049550

Group type: EXPERIMENTAL
Intervention: Hybrid closed-loop (HCL) system
Number of subjects: 29

Group type: COMPARATOR
Intervention: Medtronic MiniMed 530G with threshold suspend (control group)
Number of subjects: 29
Study: 23644758

Group type: EXPERIMENTAL
Intervention: Listening to music before surgery (Music group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine care (Control group)
Number of subjects: 100
Study: 21298283

Group type: COMPARATOR
Intervention: 25 Hz rTMS
Number of subjects: 10
Study: 19515182

Group type: EXPERIMENTAL
Intervention: 3.9-5.0 mmol/l FPG target
Number of subjects: 244

Group type: COMPARATOR
Intervention: 4.4-6.1 mmol/l FPG target
Number of subjects: 244
Study: 17919090

Group type: EXPERIMENTAL
Intervention: HIV‐1 DNA viral load (DNA‐VL) in TR mothers
Number of subjects: 66

Group type: COMPARATOR
Intervention: HIV‐1 DNA viral load (DNA‐VL) in NTR mothers
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Comparison of TR and NTR mothers
Number of subjects: 66
Study: 14985996

Group type: EXPERIMENTAL
Intervention: MAX training at 100% of maximum inspiratory pressure (MIP) for 6 weeks
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: SUB training at 80% of maximum inspiratory pressure (MIP) for 6 weeks
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no inspiratory training)
Number of subjects: 66
Study: 11231370

Group type: EXPERIMENTAL
Intervention: Furosemide 250 mg every day
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control (no furosemide)
Number of subjects: 61
Study: 10095796

Group type: EXPERIMENTAL
Intervention: Quinapril (20 mg once daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Metoprolol (100 mg once daily)
Number of subjects: 60
Study: 8142829

Group type: EXPERIMENTAL
Intervention: Medial taping of the patella
Number of subjects: 14

Group type: COMPARATOR
Intervention: Neutral taping of the patella
Number of subjects: 14

Group type: COMPARATOR
Intervention: Lateral taping of the patella
Number of subjects: 14
Study: 2905110

Group type: EXPERIMENTAL
Intervention: Piribedil (0.5 mg intravenously over 10 minutes)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 31811650

Group type: EXPERIMENTAL
Intervention: Best practice alert (BPA) linked to a Smartset
Number of subjects: 2697

Group type: COMPARATOR
Intervention: Best practice alert (BPA) alone
Number of subjects: 2697
Study: 30099857

Group type: EXPERIMENTAL
Intervention: Circadian active bright white light (BWL)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Circadian inactive dim white light (DWL)
Number of subjects: 44
Study: 27063071

Group type: EXPERIMENTAL
Intervention: Selexipag 400 μg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Warfarin 20 mg
Number of subjects: 19
Study: 24284464

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 25
Study: 23644932

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4203

Group type: EXPERIMENTAL
Intervention: Lutein (10 mg) + Zeaxanthin (2 mg)
Number of subjects: 4203

Group type: EXPERIMENTAL
Intervention: DHA (350 mg) + EPA (650 mg)
Number of subjects: 4203

Group type: EXPERIMENTAL
Intervention: Lutein + Zeaxanthin and DHA + EPA
Number of subjects: 4203

Group type: EXPERIMENTAL
Intervention: Beta carotene elimination
Number of subjects: 4203
Study: 20595224

Group type: EXPERIMENTAL
Intervention: Communication strategies training group
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Communication strategies training plus psychosocial exercise group
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Informational lecture plus psychosocial exercise group
Number of subjects: 51
Study: 18400776

Group type: EXPERIMENTAL
Intervention: Intravenous antivenom
Number of subjects: 126

Group type: COMPARATOR
Intervention: Intramuscular antivenom
Number of subjects: 126
Study: 15930213

Group type: EXPERIMENTAL
Intervention: Ibuprofen (10 mg/kg, followed by 5 mg/kg after 24 and 48 hours)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 155
Study: 12540788

Group type: EXPERIMENTAL
Intervention: 5-isosorbide mononitrate (ISMN; 10 mg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 12800045

Group type: EXPERIMENTAL
Intervention: mepivacaine
Number of subjects: 57

Group type: COMPARATOR
Intervention: sodium chlorid
Number of subjects: 57
Study: 8800885

Group type: EXPERIMENTAL
Intervention: Operations performed by consultant urologists
Number of subjects: 100

Group type: COMPARATOR
Intervention: Operations performed by trainee urologists
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Patients who absorbed irrigant fluid
Number of subjects: 100

Group type: COMPARATOR
Intervention: Patients who did not absorb irrigant fluid
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Patients with significant irrigant fluid absorption (peak breath alcohol > 300 mg/L) operated by consultant
Number of subjects: 100

Group type: COMPARATOR
Intervention: Patients with significant irrigant fluid absorption (peak breath alcohol > 300 mg/L) operated by trainee
Number of subjects: 100
Study: 1815520

Group type: EXPERIMENTAL
Intervention: Prajmalium bitartrate tablet (Neo‐Gilurytmal)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Oral solution of prajmalium bitartrate
Number of subjects: 20
Study: 6655704

Group type: EXPERIMENTAL
Intervention: Sex therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Marital therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both therapies
Number of subjects: 0
Study: 28910538

Group type: EXPERIMENTAL
Intervention: Cycling at 50 rpm
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cycling at 80 rpm
Number of subjects: 8

Group type: COMPARATOR
Intervention: Both conditions (50 rpm and 80 rpm)
Number of subjects: 8
Study: 26387037

Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TA) - single dose of 20 mg/kg
Number of subjects: 186

Group type: COMPARATOR
Intervention: Standard drains
Number of subjects: 186

Group type: COMPARATOR
Intervention: Reinfusion drains
Number of subjects: 186
Study: 24807327

Group type: EXPERIMENTAL
Intervention: Foley catheter
Number of subjects: 376

Group type: COMPARATOR
Intervention: Dinoprostone
Number of subjects: 376
Study: 22624299

Group type: EXPERIMENTAL
Intervention: Orange maize (O1, O2, O3)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Orange maize (O3)
Number of subjects: 189

Group type: COMPARATOR
Intervention: White maize
Number of subjects: 189
Study: 19697326

Group type: EXPERIMENTAL
Intervention: Screening arm with health education, visual inspection of cervix (with 4% acetic acid-VIA), and clinical breast examination (CBE)
Number of subjects: 151538

Group type: COMPARATOR
Intervention: Control arm with only health education
Number of subjects: 151538
Study: 18580364

Group type: EXPERIMENTAL
Intervention: Low-back condition with backpack loaded at 10% BW
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-back condition with backpack loaded at 20% BW
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-back condition with backpack loaded at 30% BW
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-back condition with backpack over one shoulder
Number of subjects: 10

Group type: COMPARATOR
Intervention: Low-back condition
Number of subjects: 10
Study: 16136031

Group type: EXPERIMENTAL
Intervention: HPV testing
Number of subjects: 13842

Group type: EXPERIMENTAL
Intervention: Liquid-based cytology
Number of subjects: 13842

Group type: COMPARATOR
Intervention: Negative cytological preparations with positive HPV test
Number of subjects: 13842

Group type: EXPERIMENTAL
Intervention: HPV viral load analysis
Number of subjects: 13842
Study: 14560186

Group type: EXPERIMENTAL
Intervention: SB Charitè artificial disc replacement
Number of subjects: 60

Group type: COMPARATOR
Intervention: BAK anterior interbody fusion
Number of subjects: 60
Study: 10098815

Group type: EXPERIMENTAL
Intervention: Head movement strategy (encouraged to move head)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Hand-control strategy (head kept still)
Number of subjects: 14
Study: 8729308

Group type: EXPERIMENTAL
Intervention: Esmolol 1.5 mg.kg‐1
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Lidocaine 1.5 mg.kg‐1
Number of subjects: 22
Study: 2069272

Group type: EXPERIMENTAL
Intervention: Vitamin C 3 gr/day
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Vitamin C 2 gr/day
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Vitamin C 4 gr/day
Number of subjects: 35
Study: 7039663

Group type: EXPERIMENTAL
Intervention: Complete bed rest
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ambulation as desired
Number of subjects: 40
Study: 30659292

Group type: EXPERIMENTAL
Intervention: Antioxidant treatment for 6 months (n=62)
Number of subjects: 90

Group type: COMPARATOR
Intervention: No treatment (n=28)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Antioxidant treatment (n=62)
Number of subjects: 90
Study: 29402680

Group type: EXPERIMENTAL
Intervention: Methadone maintenance treatment (MMT)
Number of subjects: 179

Group type: COMPARATOR
Intervention: No methadone treatment
Number of subjects: 179
Study: 27000465

Group type: EXPERIMENTAL
Intervention: NEPA + dexamethasone
Number of subjects: 3280

Group type: COMPARATOR
Intervention: palonosetron + dexamethasone
Number of subjects: 3280

Group type: COMPARATOR
Intervention: aprepitant + ondansetron/palonosetron + dexamethasone
Number of subjects: 3280
Study: 25131184

Group type: EXPERIMENTAL
Intervention: 1.62% testosterone gel (T-gel) for 6 months
Number of subjects: 274

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: 1.62% testosterone gel (T-gel)
Number of subjects: 274
Study: 22421734

Group type: COMPARATOR
Intervention: Neuromuscular electrical stimulation (NMES) applied to the quadriceps, tibialis anterior, and gastrocnemius muscles for 60 minutes per day.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham intervention (control) applied to the quadriceps, tibialis anterior, and gastrocnemius muscles for 60 minutes per day.
Number of subjects: 0
Study: 19536563

Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 352

Group type: COMPARATOR
Intervention: Control (placebo or best supportive care)
Number of subjects: 352
Study: 17461702

Group type: EXPERIMENTAL
Intervention: Acetaminophen 1 g twice/day
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Acetaminophen 4 g/day
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combined acetaminophen groups
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 15114096

Group type: EXPERIMENTAL
Intervention: Vasosol (VSL) machine perfusion solution
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control solution (Belzer MPS)
Number of subjects: 162
Study: 17257280

Group type: EXPERIMENTAL
Intervention: Diazoxide, 100 mg at bedtime
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26